NEJM AI Grand Rounds – Details, episodes & analysis

In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Vijay Pande, a general partner at Andreessen Horowitz (A16Z) where he leads investments in health care and life sciences. The conversation explores Pande’s journey from academia to venture capital, his views on the future of AI in health care and biomedicine, and insights into the investment landscape for biotech and health tech companies. Pande discusses the challenges and opportunities in integrating AI into medical practice, the potential for AI to democratize health care access, and his thoughts on the development of artificial general intelligence (AGI).

Transcript.

In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Rohaid Ali and Dr. Fatima Mirza, a married couple and chief residents at Brown University. The conversation explores their innovative work applying AI to health care, focusing on two major projects:

1. Using ChatGPT to simplify surgical consent forms, making them more accessible to patients. This initiative led to widespread adoption within their healthcare system and inspired similar changes in other medical documentation, and
2. Collaborating with OpenAI's Voice Engine to help a young patient who lost her voice due to a brain tumor by creating a custom AI-generated voice based on a short audio sample. Ali and Mirza discuss the challenges and opportunities of integrating AI into medical practice, emphasizing responsible deployment and human oversight.

They share insights on balancing personal and professional collaboration as a married couple working on research together. The episode features a lighthearted “newlywed game” segment, testing how well the couple knows each other’s perspectives. It concludes with Ali and Mirza offering advice to early-career doctors interested in AI and sharing their vision for AI’s future in medicine, highlighting the importance of ensuring equitable access to these technologies and the need for thoughtful implementation by medical professionals.

Transcript. 

In this episode, vanguard geneticist Dr. George Church recounts his storied career from his early fascination with computers and science to his pioneering work in genomics and synthetic biology. Dr. Church developed innovative DNA sequencing methods that enabled the first sequencing of the human genome. He was also instrumental in developing CRISPR gene editing technology. Dr. Church discusses his controversial ideas around resurrecting wooly mammoths and using genome sequencing in dating apps to prevent genetic diseases. He also provides insights into founding genomics companies and the role of AI in advancing biotechnology. As a professor of genetics at Harvard Medical School and the founder of multiple genomics companies, Dr. Church emphasizes the potential for synthetic biology and genetics to transform medicine and society.

Transcript.

In this episode, we’re joined by business magnate and investor Mark Cuban. Cuban describes his journey from humble beginnings as a self-taught programmer to becoming a successful serial entrepreneur and owner of an NBA team. Cuban shares the founding story of his pharmacy benefits company, Cost Plus Drugs, and his vision for reimagining the reimbursement system for care. He also articulates why he believes AI will be more transformative than prior technology shifts such as mobile and the internet and unpacks the potential of AI in addressing previously intractable problems in healthcare. Cuban is a self-made billionaire, bestselling author, star of Shark Tank, and owner of the Dallas Mavericks.

Transcript

In this episode, pioneering informatician Dr. Atul Butte guides listeners through his storied career, from his early days as a pediatric endocrinologist and informatician in Boston to his trailblazing work on the West Coast. Dr. Butte describes his trailblazing efforts to both harness large-scale public biomedical data and share patient data across the entire UC Health System. Dr. Butte also discusses his entrepreneurial journey, including the genesis and vision behind companies like NuMedii. Dr. Butte is the Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF and the Chief Data Scientist of the UC Health System.

Transcript

In this thought-provoking episode, Dr. Ziad Obermeyer delves into the complex issues of bias, safety, and generalizability of medical AI. Dr. Obermeyer emphasizes the importance of machine learning researchers’ task formulation, an often-overlooked yet significant determinant of bias in AI algorithms. Highlighting the dual impact of machine learning, he compares two of his works that demonstrate how AI can either exacerbate or help mitigate health care disparities. Lastly, he discusses the significant challenges encountered in the development of AI models due to siloed and inaccessible data, sharing his own experiences and solutions in tackling this issue. Dr. Obermeyer is the Blue Cross of California Distinguished Professor at the Berkeley School of Public Health, Co-Founder of Nightingale Open Science, and Co-Founder of Dandelion Health.

Transcript

Dr. Marzyeh Ghassemi has been at the forefront of medical machine learning for several years. In this episode, she describes her group’s work and her perspectives on developing and applying machine learning to understand and improve health in ways that are robust, private, and fair. Dr. Ghassemi is an Assistant Professor at MIT in Electrical Engineering and Computer Science and the Institute for Medical Engineering & Science.

Transcript

Large language models (LLMs) like ChatGPT have proven highly capable of a broad array of natural language tasks including summarizing text, generating prose, and answering questions. This episode’s two guests, Dr. Alan Karthikesalingam and Vivek Natarajan of Google, describe their team’s recent efforts to adapt and evaluate LLMs for clinical applications. Alan and Vivek took very different paths to becoming leading medical AI researchers and in this episode they also share their educational journeys and perspectives on where the field is headed. Alan is a Senior Staff Clinician Scientist and Research Lead at Google Health and Vivek is a Research Scientist at Google Health AI.

Transcript

Dr. Michael Abramoff is a renowned ophthalmologist and medical AI pioneer. In this episode, we explore his groundbreaking work that led to the first FDA-authorized device that does not require a physician, IDx-DR, which detects more than mild diabetic retinopathy from digital images of the eye. Dr. Abramoff also reflects on the challenges of commercialization, AI reimbursement, and the ethical imperatives for AI in health care centered around patient benefit. Dr. Abramoff is the Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the University of Iowa and Founder & Executive Chairman of Digital Diagnostics, an autonomous AI diagnostics company that developed IDx-DR.

Transcript

Dr. Peter Lee has shaped computer science from academia, government, and industry. He has chaired a major computer science department, built a new technology office at DARPA, and now serves as Corporate Vice President at Microsoft, where he leads Microsoft Research and its nine worldwide laboratories. In this episode, Peter reveals Microsoft’s interest in health care and the origins of the OpenAI and Microsoft partnership, and he speculates on how large language models like ChatGPT will transform medicine.

Transcript